s
i
ANANBIOANAL - 2010
Pharmaceutical R & D Summit
doi:10.4172/2155-9872.1000064
Bioinformatics for Drug Formulations and Delivery System
Basavaraj K. Nanjwade
KLE University’s College of Pharmacy, Belgaum, Karnataka, India
D
rug companies spend more than $5 billion per year on IT. So what does this
mean for drug delivery and formulation development as we know? An injectable
or solid oral immediate or sustained released are “no brainers” for pharma in terms of
dosage form selection. Now go have fun with solubility and stability, and its headache
time or cocktail time, depending where you are in the world and your choice of vice.
To combine the right chemical ingredients in the right proportions, driving the right
reactions under the right conditions to achieve the right end product with the right
properties requires an incredible amount of information and an incredible amount
of knowledge. All this information and knowledge has to be available at the point
of formulation. Managing the formulation process without iteration is the secret
to reducing development time. Having software to provide the right information
at the right place at the right time and you avoid costly, embarrassing mistakes
and eliminate duplicate work. Today, a formulator could even identify promising
formulation leads, store, and manage a pharma company’s formulation portfolio or
library. To quickly discard all about the leading options and eliminating time wasted
on low probability routes while identifying the best and least expensive ingredient
mix can save money and time. In the final analysis, this will allow drug delivery
companies to be in a greater position of strength. Drug delivery companies can
improve their odds of solidifying licensing and development deals on better terms.
ANALBIOANAL-2010
O
M
I
C
S
P
i
u
h
b
l
n
g
G
r
o
u
p